Public Petition About Conflicts of Interest At The FDA

I received an e-mail this morning from Leslie who was the producer and director of the short video I filmed about the Provenge issue at the FDA. (you can view the video at: Joel's Provenge Video Leslie asked that I sign a petition asking for a formal inquiry into the conflict of interest (COI) issues [...]

Again, Physican Conflicts of Interests

Today’s New York Times carried a story written by Reed Abelson entitled “Financial Ties Are Cited as Issue in Spine Study.” The story explained that some of the nation’s most prominent spine surgeons hailed as a medical breakthrough a study of nearly 240 patients with lower back pain. The doctors said that Prodisc, an artificial [...]

A Possible Congressional Investigation Into The Issue Of Conflicts Of Interest At the FDA’s Provenge Advisory Hearing

Many of my prior posts about Provenge have discussed the issue of what appeared to be a conflict of interest of some of the members on the FDA advisory committee that reviewed the drug. When the committee voted to recommend that Provenge be approved, among those members who voted against the approval were Drs. Scher [...]

By |2017-10-19T10:58:50-04:00December 13th, 2007|Advanced Prostate Cancer, FDA, Provenge, Uncategorized, vaccines|0 Comments

Should Terminally Ill Patients Have Access To Promising New Therapies – A “You Tube” Video

I have had the privilege of working with Leslie Mulkey, an independent video producer on a short "You Tube" video about Provenge. Our hope is that our question, "Should terminally ill patients have access to promising new therapies?" will become a part of the next national presidential debate. You can view our video by clicking [...]

The Wall Street Journal’s Opinion Piece – The FDA’s Deadly Track Record

An opinion piece written by Ronald Trowbridge and Steven Walker appeared today in the WSJ. The piece is centered on the recent decision of the full D.C. Circuit Court of Appeals that reversed its own smaller panel’s 2 to 1 decision to allow dying, terminal patient’s access to investigational drugs that have been found to [...]

Go to Top